
<table style="text-align:center"><caption><strong>Poisson Models of Orphan Drug Market Authorizations (Not adjusted for Error Structure)</strong></caption>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"></td><td colspan="6"><em>Dependent variable:</em></td></tr>
<tr><td></td><td colspan="6" style="border-bottom: 1px solid black"></td></tr>
<tr><td style="text-align:left"></td><td colspan="6">Annual Number of Market Authorized Orphan Drugs</td></tr>
<tr><td style="text-align:left"></td><td>(1)</td><td>(2)</td><td>(3)</td><td>(4)</td><td>(5)</td><td>(6)</td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD)</td><td></td><td></td><td>-0.0004</td><td>0.016</td><td>-0.0003</td><td>0.016</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td>(0.006)</td><td>(0.043)</td><td>(0.007)</td><td>(0.043)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">US</td><td>1.396<sup>***</sup></td><td>0.649<sup>***</sup></td><td>0.650<sup>***</sup></td><td>0.890</td><td>0.650<sup>***</sup></td><td>0.895</td></tr>
<tr><td style="text-align:left"></td><td>(0.080)</td><td>(0.185)</td><td>(0.187)</td><td>(0.658)</td><td>(0.187)</td><td>(0.660)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004</td><td>0.110<sup>***</sup></td><td>0.056<sup>***</sup></td><td>0.056<sup>***</sup></td><td>0.037</td><td>0.056<sup>***</sup></td><td>0.036</td></tr>
<tr><td style="text-align:left"></td><td>(0.007)</td><td>(0.014)</td><td>(0.016)</td><td>(0.054)</td><td>(0.016)</td><td>(0.055)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual GDP Growth Rate Per Capita</td><td></td><td></td><td></td><td></td><td>-0.083</td><td>-0.127</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td>(1.300)</td><td>(1.304)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004:US</td><td></td><td>0.069<sup>***</sup></td><td>0.070<sup>***</sup></td><td>0.091</td><td>0.070<sup>***</sup></td><td>0.091</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.016)</td><td>(0.020)</td><td>(0.059)</td><td>(0.021)</td><td>(0.059)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD):US</td><td></td><td></td><td></td><td>-0.016</td><td></td><td>-0.017</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td>(0.043)</td><td></td><td>(0.043)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Intercept</td><td>1.288<sup>***</sup></td><td>1.866<sup>***</sup></td><td>1.872<sup>***</sup></td><td>1.639<sup>**</sup></td><td>1.872<sup>***</sup></td><td>1.634<sup>**</sup></td></tr>
<tr><td style="text-align:left"></td><td>(0.105)</td><td>(0.158)</td><td>(0.184)</td><td>(0.640)</td><td>(0.184)</td><td>(0.642)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">Observations</td><td>36</td><td>36</td><td>36</td><td>36</td><td>36</td><td>36</td></tr>
<tr><td style="text-align:left">Log Likelihood</td><td>-127.327</td><td>-118.375</td><td>-118.373</td><td>-118.300</td><td>-118.371</td><td>-118.296</td></tr>
<tr><td style="text-align:left">Akaike Inf. Crit.</td><td>260.654</td><td>244.750</td><td>246.746</td><td>248.601</td><td>248.742</td><td>250.591</td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"><em>Note:</em></td><td colspan="6" style="text-align:right"><sup>*</sup>p<0.1; <sup>**</sup>p<0.05; <sup>***</sup>p<0.01</td></tr>
</table>
